ALABAMA: Groundbreaking Medical AI Program to Hit Market in Near Future

Researchers at the University of Alabama in Huntsville created an artificial intelligence program that watches chemical reactions in cells on a mass scale to help biophysicists understand how the reactions happen, knowledge that will speed up the development and improve the quality of new drugs. Kannan Grant, director of UAH's commercialization office, said the office will help the researchers find a path to develop their patented technology within the next six months.

The technology utilizes complex analytics programs to rapidly observe vast quantities of complex interactions between chemicals within living cells. The application of sheer computational power to these interactions enable biophysicists to more quickly and efficiently discern the laws governing those interactions, resulting in faster, more precise, and even less expensive development of pharmaceuticals.